The Center for Cellular Therapies and Cancer Immunology (CCTCI) at UT Southwestern Medical Center is recruiting tenure-track faculty at all academic ranks (Assistant, Associate, or Full Professor). We seek innovative scientists with expertise in immune engineering who are eager to develop transformative technologies and biologics to treat cancer.
About the Center
The CCTCI is a newly established, interdisciplinary center dedicated to accelerating the discovery and clinical translation of next-generation immunotherapies, including first-in-human Phase I trials. The Center leverages UT Southwestern's world-class infrastructure in cellular manufacturing, genomics, and early-phase clinical development to bridge the bench and bedside.
Research Areas of Interest
We welcome applicants using cutting-edge tools to investigate and manipulate the immune system for therapeutic gain. Specific areas of interest include, but are not limited to:
Applicants working at the interface of computational, synthetic, and translational immunology are especially encouraged to apply.
Interested candidates should submit the following materials:
UT Southwestern Medical Center is committed to an educational and working environment that provides equal opportunity to all members of the University community. As an equal opportunity employer, UT Southwestern prohibits unlawful discrimination, including discrimination on the basis of race, color, religion, national origin, sex, sexual orientation, gender identity, gender expression, age, disability, genetic information, citizenship status, or veteran status.
This position is security-sensitive and subject to Texas Education Code 51.215, which authorizes UT Southwestern to obtain criminal history record information.
Appointment rank will be commensurate with academic accomplishment and experience. Consideration may be given to applicants seeking less than a full-time schedule.
To learn more about the benefits UT Southwestern offers, visit https://www.utsouthwestern.edu/employees/hr-resources/
Benefits